Novonesis shares rose 10.64%, leading the Europe-wide Stoxx 600 after the Danish biosolutions group reported sharp sales growth and upgraded its guidance. The Copenhagen-listed stock jumped more than 10% to a one-year high of 455.50 Danish kroner in early afternoon European trade and is up 12% year to date.